Review article · 2026 · Open access

TREM2 in neurodegeneration and diseases

Altaf A. Abdulkhaliq, Glowi A. Alasiri, Bonglee Kim, Johra Khan, Amir Ajoolabady, Shimaa Mohammad Yousof, Jun Ren, J Tuomilehto, Anwar Borai, Bahauddeen M. Alrfaei, Domenico Praticò

Molecular Psychiatry, 31(7), 3978–3986 · Published 6 March 2026 · DOI 10.1038/s41380-026-03505-7

Open PDFView at the publisherCite this paper

In brief

“TREM2 in neurodegeneration and diseases” is a 2026 review article by Altaf A. Abdulkhaliq and 10 co-authors, published in Molecular Psychiatry. OpenAlex counts 28 citations as of 17 November 2026, which puts it in the top 1% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Molecular Psychiatry.

Citations
28
Most cited in
2026 (28)
Field-weighted impact
15.17
References
162
Authors
11

Abstract

Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell surface transmembrane receptor from the TREM receptor family, predominantly expressed on the microglia in the central nervous system (CNS). TREM2-initiated signaling plays a crucial role in regulating neuroinflammation and neurodegeneration, particularly in the context of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), through the activation of downstream signaling pathways and transcriptional regulation of relevant genes. In this review, we aim to provide a concise review of the role and mechanistic implications of TREM2 in neurodegeneration and neuroinflammation, with a specific focus on AD and PD. We will discuss the most recent preclinical studies to highlight current advancements in the field. This review is intended to support both basic researchers and clinicians by enhancing their understanding of microglial function in the pathophysiology of AD and PD, as well as its role in neuroinflammation and neurodegeneration. Ultimately, we hope this contribution will pave the way for new discoveries and the development of potential therapeutic interventions.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Abdulkhaliq, A. A., Alasiri, G. A., Kim, B., Khan, J., Ajoolabady, A., Yousof, S. M., Ren, J., Tuomilehto, J., Borai, A., Alrfaei, B. M., & Praticò, D. (2026). TREM2 in neurodegeneration and diseases. Molecular Psychiatry, 31(7), 3978–3986. https://doi.org/10.1038/s41380-026-03505-7

MLA 9

Abdulkhaliq, Altaf A., et al. “TREM2 in neurodegeneration and diseases.” Molecular Psychiatry, vol. 31, no. 7, 2026, pp. 3978–3986. https://doi.org/10.1038/s41380-026-03505-7.

Chicago

Abdulkhaliq, Altaf A., Glowi A. Alasiri, Bonglee Kim, Johra Khan, Amir Ajoolabady, Shimaa Mohammad Yousof, Jun Ren, et al. 2026. “TREM2 in neurodegeneration and diseases.” Molecular Psychiatry 31 (7): 3978–3986. https://doi.org/10.1038/s41380-026-03505-7.

Harvard

Abdulkhaliq, A. A. et al. (2026) ‘TREM2 in neurodegeneration and diseases’, Molecular Psychiatry, 31(7), pp. 3978–3986. doi:10.1038/s41380-026-03505-7.

IEEE

A. A. Abdulkhaliq et al., “TREM2 in neurodegeneration and diseases,” Molecular Psychiatry, vol. 31, no. 7, pp. 3978–3986, 2026, doi: 10.1038/s41380-026-03505-7.

BibTeX

@article{abdulkhaliq2026trem,
  title     = {{TREM2 in neurodegeneration and diseases}},
  author    = {Abdulkhaliq, Altaf A. and Alasiri, Glowi A. and Kim, Bonglee and Khan, Johra and Ajoolabady, Amir and Yousof, Shimaa Mohammad and Ren, Jun and Tuomilehto, J and Borai, Anwar and Alrfaei, Bahauddeen M. and Praticò, Domenico},
  journal   = {Molecular Psychiatry},
  year      = {2026},
  volume    = {31},
  number    = {7},
  pages     = {3978--3986},
  doi       = {10.1038/s41380-026-03505-7},
  url       = {https://doi.org/10.1038/s41380-026-03505-7}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms

  • TREM2
  • microglia
  • neuroinflammation
  • neurodegeneration
  • Alzheimer's disease
  • Parkinson's disease
  • microglial activation
  • neurodegenerative disease therapeutics

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Abdulkhaliq, A. A., Alasiri, G. A., Kim, B., Khan, J., Ajoolabady, A., Yousof, S. M., Ren, J., Tuomilehto, J., Borai, A., Alrfaei, B. M., & Praticò, D. (2026). TREM2 in neurodegeneration and diseases. Molecular Psychiatry, 31(7), 3978–3986. https://doi.org/10.1038/s41380-026-03505-7

How many times has this paper been cited?

28 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Molecular Psychiatry: sign in and open the PDF from this page.

Who wrote this paper?

Altaf A. Abdulkhaliq, Glowi A. Alasiri, Bonglee Kim, Johra Khan, Amir Ajoolabady, Shimaa Mohammad Yousof, Jun Ren, J Tuomilehto, Anwar Borai, Bahauddeen M. Alrfaei, Domenico Praticò.

What is the DOI of this paper?

10.1038/s41380-026-03505-7, permanently at https://doi.org/10.1038/s41380-026-03505-7. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.